Alzheimer Disease Clinical Trials in Cambridge, Massachusetts

3 studies are recruiting for alzheimer disease in Cambridge, Massachusetts right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Gamma Light and Sound Stimulation to Prevent Dementia in Cognitively Normal People at Risk for Alzheimer's Disease

    Alzheimer's disease (AD) is characterized by significant memory loss, toxic protein deposits (amyloid and tau) in the brain, and changes in the gamma frequency band on EEG. Gamma waves are important for memory, and in patients with AD, there are fewer gamma waves in the brain. The Tsai lab found th…

    Stage
    Not phased
    Ages
    55 to 90
    Site
    Massachusetts Institute of Technology, Cambridge, Massachusetts
    Locations
    2 in total
    Run by
    Massachusetts General Hospital

    See if you can join NCT05776641 on ClinicalTrials.gov

  2. Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy

    Alzheimer's disease (AD) is characterized by significant memory loss, toxic protein deposits amyloid and tau) in the brain, and changes in the gamma frequency band on EEG. The investigator's lab found that boosting gamma waves in AD mouse models using light and sound stimulation at 40Hz not only re…

    Stage
    Not phased
    Ages
    65 to 100
    Site
    Massachusetts Institute of Technology, Cambridge, Massachusetts
    Run by
    Massachusetts Institute of Technology

    See if you can join NCT05655195 on ClinicalTrials.gov

  3. Brain Effects of Gamma Frequency Sensory Stimulation (40Hz Light, Sound and Other Devices)

    Despite the huge healthcare and economic impact of AD, there is still no disease modifying therapeutics available. In fact, the available therapeutics show low efficacy at best in the treatment of cognitive impairment in dementia. Development of a non-invasive medical device that is effective in sl…

    Stage
    Phase 2
    Ages
    18 to 100
    Site
    MIT, Cambridge, Massachusetts
    Run by
    Massachusetts Institute of Technology

    See if you can join NCT07496918 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.